WebGlycogen storage disease type IIa, also called Pompe disease, (not to be confused with GSD-IIb, Danon disease, which has similar symptoms but a different gene).It is an autosomal recessive metabolic disorder which damages muscle and nerve cells throughout the body. It is caused by an accumulation of glycogen in the lysosome due to deficiency of the … WebJan 19, 2024 · The gene linked to Pompe disease is known as the GAA gene. In healthy people, it produces the GAA enzyme. This enzyme breaks down a sugar called glycogen …
Pompe Disease – newbornscreening.info
WebPompe disease (GSDII) is a genetically inherited condition caused by a mutation of a gene that is responsible for the production of lysosomal acid-alpha-glucosidase (GAA). GAA is an enzyme responsible for the breakdown of glycogen, a form of glucose that is used as an energy supply to organs. In the absence of GAA, the breakdown of glycogen ... WebAug 31, 2007 · Pompe disease is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% … inc. official
What is Pompe disease? - Sanofi Campus
WebOct 10, 2024 · Pompe disease is an inherited genetic disorder, meaning children inherit the gene mutations that cause it from their parents. However, as mentioned earlier, it is an autosomal recessive genetic ... WebNov 17, 2024 · Glycogen-storage disease type II (GSDII), also referred to as Pompe disease, is an autosomal recessive disorder that results from the deficiency of acid alpha-glucosidase, a lysosomal hydrolase. Pompe first described the disease in 1932 when he was presented with a 7-month-old girl who died after developing idiopathic hypertrophic … WebJul 27, 2024 · Glycogen storage disease type II, also known as Pompe disease or acid maltase deficiency disease, is an inherited lysosomal storage disorder characterized by abnormal glycogen accumulation within lysosomes. It is a multisystem disorder involving the heart, skeletal muscle and liver. It is caused by a deficiency of lysosomic acid α-1,4 … inc. oqlf